{"_id": "538631e838f0d83ab049030b", "print_page": null, "blog": [], "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS"}, "multimedia": [], "source": "AP", "type_of_material": "News", "news_desk": null, "snippet": "German drugmaker Boehringer Ingelheim said Wednesday it has agreed to pay $650 million to settle thousands of U.S. claims questioning the marketing and safety of its popular blood thinner Pradaxa....", "document_type": "article", "subsection_name": null, "word_count": "393", "headline": {"print_headline": "$650M Settlement Reached Over Blood Thinner", "main": "$650M Settlement Reached Over Blood Thinner"}, "lead_paragraph": "German drugmaker Boehringer Ingelheim said Wednesday it has agreed to pay $650 million to settle thousands of U.S. claims questioning the marketing and safety of its popular blood thinner Pradaxa.", "slideshow_credits": null, "keywords": [], "pub_date": "2014-05-28T14:58:21Z", "section_name": "U.S.", "abstract": null, "web_url": "http://www.nytimes.com/aponline/2014/05/28/us/ap-us-blood-thinner-settlement.html"}